Publications

Main literature
Dias C et al. De novo variants in TCF7L2 are associated with a syndromic neurodevelopmental disorder.Am J Med Genet A, 2021 Aug;185(8):2384-2390. PMID: 34003604.

Supportive literature
Darbandi et al. Five autism-associated transcriptional regulators target shared loci proximal to brain-expressed genes.Cell Rep, 2024 Jun 25;43(6):114329. PMID: 38850535.

Szewczyk et al. Astrocytic β-catenin signaling via TCF7L2 regulates synapse development and social behavior. Mol Psychiatry. 2024 Jan;29(1):57-73. PMID: 37798419.

Tuncay et al. The genetics of autism spectrum disorder in an East African familial cohort. Cell Genom, 2023 May 11;3(7):100322. PMID: 37492102.

Qi et al. TCF7L2 acts as a molecular switch in midbrain to control mammal vocalization through its DNA binding domain but not transcription activation domain.Mol Psychiatry, 2023 Apr;28(4):1703-1717. PMID: 36782064.

Satterstrom et al. Large-scale exome sequencing study implicates both developmental and functional changes in the neurobiology of autism.Cell. 2020;180:568–.e523. PMID: 31981491.

Wang et al. Large-scale targeted sequencing identifies risk genes for neurodevelopmental disorders.Nat Commun. 2020 Oct 1;11:4932. PMID: 33004838.

Bem J et al. Wnt/β-catenin signaling in brain development and mental disorders: keeping TCF7L2 in mind.FEBS Lett. 2019 Jul;593(13):1654-1674. PMID: 31218672.

Iossifov and O’Roak et al. The contribution of de novo coding mutations to autism spectrum disorder.Nature. 2014 Oct 29;515(7526):216–221. PMID: 25363768.